Skip to main content
Skip to main content

Antimicrobial susceptibility testing of Spanish field isolates of Brachyspira hyodysenteriae

This study is the first conducted in Spain to evaluate antimicrobial susceptibility of field isolates of Brachyspira hyodysenteriae. One hundred and eight isolates of the bacterium, recovered from different Spanish swine farms between 2000 and 2007, were investigated. The minimum inhibitory concentrations (MIC) of erythromycin, tylosin, tiamulin, valnemulin, clindamycin and lincomycin were determined using a broth microdilution technique. Most of the isolates showed poor susceptibility to erythromycin (MIC(90)>256 microg/ml), tylosin (MIC(90)>256 microg/ml), clindamycin (MIC(90)>4 microg/ml) and lincomycin (MIC(90)=128 microg/ml). Reduced susceptibility to tiamulin and valnemulin was observed with a MIC>2 microg/ml in 17.6% and 7.41% of the B. hyodysenteriae isolates, respectively. Moreover, a survival analysis permitted the detection of an increasing trend in the MIC values for almost all the antimicrobials used in the treatment of swine dysentery when comparing recent isolates (from 2006 to 2007) with those recovered in earlier years (between 2000 and 2004).

Due Date Approaches for Industrial Partners Submissions

The American Association of Swine Veterinarians invites submissions for the Industrial Partners portion of the 41st AASV Annual Meeting, to be held March 6-9, 2010, in Omaha, Nebraska. This is an opportunity for commercial companies to make brief presentations of a technical, educational nature to members of the AASV. Requests for participation must be received by October 1.

Student Seminar Abstracts due Friday, Sept 25; New Submission Process

Friday, September 25 is the last day for veterinary students to submit abstracts for the AASV 2010 Student Seminar and Veterinary Student Scholarship competition. Application materials are available on the AASV website for veterinary students wishing to participate in the Student Seminar on Sunday, March 7 during the AASV 2010 Annual Meeting in Omaha, Nebraska. Changes have been made to the submission process, so students and their faculty advisors are encouraged to review the application materials carefully.

2009 International PRRS Symposium Announced

The 2009 International PRRS Symposium: “Molecular, Immunological, Genetic and Epidemiological Approaches for PRRSV Control” will be held Friday December 4, 2009 to Saturday December 5, 2009 at the downtown Marriott in Chicago. Website: http://www.prrssymposium.org. The symposium will precede the Conference of Researcher Workers in Animal Diseases (CRWAD).

People on the Move: Dr. Troy Kaiser

Dr. Troy Kaiser has relocated to St. Joseph, Missouri, to accept a position in Biological Clinical Development with Boehringer Ingelheim Vetmedica, Inc. He was formerly employed by Pfizer Animal Health, and was based in Kalamazoo, Michigan. Updated contact information for Dr. Kaiser is available at http://www.aasv.org/members/only/directory.php. Are you on the move? If so, let us know at aasv@aasv.org.

Ascaris suum Infection Negatively Affects the Response to a Mycoplasma hyopneumoniae vaccination and Subsequent Challenge Infection in Pigs

Since their first introduction more than a century ago, vaccines have become one of the most cost-effective tools to prevent and manage infectious diseases in human and animal populations. It is vital to understand the possible mechanisms that may impair optimal vaccine efficacy. The hypothesis posed in this study was that a concurrent Ascaris suum infection of pigs vaccinated with a Mycoplasma hyopneumoniae (Mh) vaccine would modulate the protective immune response to a subsequent challenge infection. Four groups of pigs were either (1) untreated (group C), (2) vaccinated against Mh 3 weeks after the start of the study (group V), (3) given a trickle infection with A. suum throughout the study (group A), or (4) given a trickle infection with A. suum and vaccinated against Mh (group AV). All pigs were subsequently inoculated with live Mh bacteria 4 weeks after the Mh vaccination and necropsied after another 4 weeks. All pigs in group V sero-converted 3 weeks after vaccination (100%), as opposed to only 33% of group AV pigs that were Mh-vaccinated and given A. suum. At the end of the study, only 78% of pigs in group AV had sero-converted. Pigs in group AV had a higher mean percentage of lung pathology and the variation was significantly higher in these pigs compared to pigs in group V. The pattern of gene expression in the lungs and draining lymph nodes indicated a local Th2-skewed response induced by A. suum. Our study indicated that A. suum significantly compromised the effect of Mh vaccination. The impact of reduced vaccine efficacy caused by a common gastrointestinal helminth emphasises the importance of parasite control. More focus should be put into this area of research to outline the practical consequences of this interaction, and to be able to predict, prevent and correct negative interactions.

People on the Move: Dr. Peter Juul Kristensen

Dr. Peter Juul Kristensen has accepted a position as Business Unit Manager, Swine for Central and Eastern Europe with Boehringer Ingelheim (BI). Effective October 2009, Dr. Kristensen will be heading up the swine business for Boehringer Ingelheim in 15 countries in Central and Eastern Europe. Most recently, he was European Key Account Manager for BI. Contact information for Dr. Kristensen will remain the same, and is available at http://www.aasv.org/members/only/directory.php. Are you on the move? If so, let us know at aasv@aasv.org.